FDA Adverse Event Malfunction Summary report: N

TAXUS LIBERTE ATOM PACLITAXEL-ELUTING CORONARY STENT SYSTEM

MDR report key: 1963251 · Received January 19, 2011

Report

Report Number
2134265-2011-00111
Event Type
Malfunction
Date Received
January 19, 2011
Date of Event
December 22, 2010
Report Date
January 13, 2011
Manufacturer
BOSTON SCIENTIFIC - MAPLE GROVE
Product Code
NIQ
PMA / PMN Number
P060008
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

DEVICE IS A COMBINATION PRODUCT. DEVICE EVALUATION: RETURNED PRODUCT CONSISTED OF A TAXUS LIBERTE STENT DELIVERY SYSTEM CATHETER. THE STENT HAD MOVED 1MM FROM THE PROXIMAL MARKERBAND. A STRUT IN THE SIXTH PROXIMAL ROW WAS LIFTED. THE MAJORITY OF THE STENT WAS MANGLED AND STRETCHED 30MM PAST THE TIP. MICROSCOPIC INSPECTION OF THE REMAINDER OF THE DEVICE PRESENTED NO OTHER DAMAGE OR IRREGULARITIES. THE MANUFACTURING BATCH RECORD REVIEW CONFIRMED THAT THE DEVICE MET ALL MATERIAL, ASSEMBLY AND PERFORMANCE SPECIFICATIONS. THE MOST PROBABLE ROOT CAUSE IS OPERATIONAL CONTEXT AS DEVICE PERFORMANCE WAS LIMITED DUE TO ANATOMICAL AND/OR PROCEDURAL FACTORS. (B)(4).

Description of Event or Problem · 1

REPORTABLE BASED ON THE PRODUCT ANALYSIS COMPLETED ON (B)(6) 2011. IT WAS REPORTED THAT DURING A CORONARY STENTING TREATMENT PROCEDURE, THE DEVICE WAS UNABLE TO CROSS THE LESION. THE LESION WAS LOCATED IN THE HIGHLY CALCIFIED LEFT ANTERIOR DESCENDING ARTERY. THE PHYSICIAN ADVANCED THE 2.25X20MM TAXUS LIBERTE STENT TO THE LESION BUT WAS UNABLE TO CROSS. THE PROCEDURE WAS COMPLETED WITH ANOTHER 2.25X20MM TAXUS LIBERTE STENT. NO COMPLICATIONS WERE REPORTED AND THE PATIENT'S STATUS IS STABLE. HOWEVER, THE RETURNED PRODUCT ANALYSIS REVEALED THAT THERE WAS STENT DAMAGE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TAXUS LIBERTE ATOM PACLITAXEL-ELUTING CORONARY STENT SYSTEM CORONARY DRUG-ELUTING STENT NIQ BOSTON SCIENTIFIC - MAPLE GROVE H7493893620220 13397754

Patients

Seq Age Sex Outcome Treatment
1 70 YR